FDA Approves Celgene’s Otezla for PsA
The federal Food and Drug Administration has given its nod to Otezla (apremilast) for the treatment of adults with active psoriatic arthritis (PsA).
Tag: psoriatic arthritis
All
LatestSorry, No Posts Found
All
Latest
FDA Clears Restylane Contour for Temple Hollowing
The expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.
